GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,389,000 | -56.9% | 115,860 | -51.4% | 0.48% | -11.9% |
| Q3 2019 | $10,178,000 | +137.7% | 238,479 | +122.9% | 0.54% | +227.7% |
| Q2 2019 | $4,281,000 | +6.1% | 106,978 | +10.7% | 0.17% | -28.8% |
| Q1 2019 | $4,036,000 | +25.3% | 96,600 | +29.3% | 0.23% | +385.4% |
| Q2 2017 | $3,221,000 | -42.7% | 74,700 | -42.7% | 0.05% | -74.2% |
| Q3 2016 | $5,624,000 | +84.0% | 130,400 | +72.9% | 0.19% | +25.7% |
| Q1 2016 | $3,057,000 | +341.8% | 75,400 | +402.7% | 0.15% | +124.2% |
| Q1 2015 | $692,000 | +5.3% | 15,000 | +4.9% | 0.07% | -48.0% |
| Q3 2014 | $657,000 | +21.9% | 14,300 | +41.6% | 0.13% | +388.5% |
| Q1 2014 | $539,000 | +98.2% | 10,100 | +98.0% | 0.03% | 0.0% |
| Q4 2013 | $272,000 | -85.9% | 5,100 | -86.8% | 0.03% | -92.4% |
| Q2 2013 | $1,928,000 | – | 38,600 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |